+86-576-88205808
Examorelin, also known as Hexarelin, is a growth hormone-releasing factor (GHRF) agonist potentially for the treatment of cardiac diseases.
[1]. Huang J, et al. The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway. Int Heart J. 2017 Apr 6;58(2):257-263.
[2]. Zhao Y, et al. Hexarelin Protects Rodent Pancreatic Β-Cells Function from Cytotoxic Effects of Streptozotocin Involving Mitochondrial Signalling Pathways In Vivo and In Vitro. PLoS One. 2016 Feb 26;11(2):e0149730.
Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.
Address:Economic Developed Zone of Taizhou Zhejiang China